Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker DTIL
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Ting Jia | 1.65M | 5.7% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Octagon Investments Master Fund LP | 1.65M | 5.7% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Octagon Capital Advisors LP | 1.65M | 5.7% | SCHEDULE 13G/A ↗ |
| Oct 27, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | BlackRock, Inc. | 1.38M | 5.0% | SCHEDULE 13G ↗ |
| Aug 24, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Benjamin Weinstein | 1.11M | 4.0% | SCHEDULE 13G/A ↗ |
| Jul 29, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Ryan M. Lane | 1.31M | 5.0% | SCHEDULE 13G/A ↗ |
| Jul 29, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Empery Asset Management, LP | 1.31M | 5.0% | SCHEDULE 13G/A ↗ |
| Jul 20, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Weston Nichols | 1.39M | 5.4% | SCHEDULE 13G ↗ |
| Jul 20, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Lynx1 Capital Management LP | 1.39M | 5.4% | SCHEDULE 13G ↗ |
| Apr 15, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Ryan M. Lane | 1.97M | 7.6% | SCHEDULE 13G/A ↗ |
| Apr 15, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Empery Asset Management, LP | 1.97M | 7.6% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners IV, Inc | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners III, Inc | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners International, LP | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners, LP | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Kevin Tang | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Management, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Weston Nichols | 993,913 | 4.1% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Lynx1 Capital Management LP | 993,913 | 4.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Andrew Gundlach | 1.90M | 8.2% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Bleichroeder Holdings LLC | 1.90M | 8.2% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Bleichroeder LP | 1.90M | 8.2% | SCHEDULE 13G/A ↗ |
| Feb 10, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Ting Jia | 2.33M | 10.0% | SCHEDULE 13G ↗ |
| Feb 10, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Octagon Investments Master Fund LP | 2.33M | 10.0% | SCHEDULE 13G ↗ |
| Feb 10, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Octagon Capital Advisors LP | 2.33M | 10.0% | SCHEDULE 13G ↗ |
| Jan 27, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | abrdn Inc. | 2.14M | 8.9% | SCHEDULE 13G ↗ |
| Jan 27, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Aberdeen Group plc | 2.14M | 8.9% | SCHEDULE 13G ↗ |
| Jan 22, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Ryan M. Lane | 2.30M | 10.0% | SCHEDULE 13G ↗ |
| Jan 22, 2026 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Empery Asset Management, LP | 2.30M | 10.0% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Weston Nichols | 1.04M | 8.8% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | LYNX1 Capital Management LP | 1.04M | 8.8% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Andrew Gundlach | 1.07M | 9.7% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Bleichroeder Holdings LLC | 1.07M | 9.7% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G | DTIL Precision BioSciences, Inc. | Bleichroeder LP | 1.07M | 9.7% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Matthew Smith | 1.12M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Readout Holdings GP, LLC | 906,437 | 7.6% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | ROC Holdings SPV II, LP | 906,437 | 7.6% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Readout Capital GP, LLC | 1.11M | 9.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Readout Capital, LP | 1.11M | 9.3% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Marc Schneidman | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Aquilo Capital Management, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Aquilo Capital, L.P. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Novartis AG | 413,581 | 3.7% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Novartis Pharma AG | 413,581 | 3.7% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners IV, Inc | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners III, Inc | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners International, LP | 294,650 | 2.8% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Partners, LP | 378,682 | 3.6% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Kevin Tang | 673,332 | 6.4% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | DTIL Precision BioSciences, Inc. | Tang Capital Management, LLC | 673,332 | 6.4% | SCHEDULE 13G/A ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances